Ross Moat, Chief Commercial Officer: Kiniksa Pharmaceuticals International KNSA Sell · Filed 25/04/23

Trade details

Type: Insider sale
Amount: $370,475.11
Shares · price: 18,259 sh · $20.29 a share
Held after: 9,415 sh
Stock: Kiniksa Pharmaceuticals International KNSA
Person: Ross MoatChief Commercial Officer
Trade date: 25/04/21
Filed: 25/04/23
Days to filing: 2 days

Sold 66.0% of holdings

Share of holding sold: 66.0%

Kiniksa Pharmaceuticals International trades, last 26 weeks

What else happened in Kiniksa Pharmaceuticals International around then

Filed or reported within 30 days of the trade day · 25/03/22~25/05/21

Ross Moat's recent trades

Ross MoatCOO
Sell10b5-1 planKiniksa Pharmaceuticals International
Sell10b5-1 plan
Kiniksa Pharmaceuticals International
KNSA
$79.5K
1,703 sh
$79.5K
Filed 04/13
Traded 04/09
Ross MoatCOO
Planned sale10b5-1 planKiniksa Pharmaceuticals International
Planned sale10b5-1 plan
Kiniksa Pharmaceuticals International
KNSA
$79.5K
1,703 sh
$79.5K
Filed 04/09
Traded 04/09
Ross MoatCOO
Sell10b5-1 planKiniksa Pharmaceuticals International
Sell10b5-1 plan
Kiniksa Pharmaceuticals International
KNSA
$115K
2,367 sh
$115K
Filed 04/08
Traded 04/06
Ross MoatCOO
Planned sale10b5-1 planKiniksa Pharmaceuticals International
Planned sale10b5-1 plan
Kiniksa Pharmaceuticals International
KNSA
$115K
2,367 sh
$115K
Filed 04/06
Traded 04/06
Ross MoatChief Corp. & Comm. Officer
Sell10b5-1 planKiniksa Pharmaceuticals International
Sell10b5-1 plan
Kiniksa Pharmaceuticals International
KNSA
$124.4K
3,523 sh
$124.4K
Filed 25/09/08
Traded 25/09/04